Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Listen: Apple Is Entering The Healthcare Market

It looks like Apple will be heading into the Healthcare Industry as their upcoming IOS 11.3 update will enable patients to view EMR’s or Electronic Medical Records as well as other pertinent clinical information right from their Apple device. This new Health Records feature utilizes the existing Health app currently on devices and goes…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

It looks like Apple will be heading into the Healthcare Industry as their upcoming IOS 11. 3 update will enable patients to view EMR’s or Electronic Medical Records as well as other pertinent clinical information right from their Apple device. This new Health Records feature utilizes the existing Health app currently on devices and goes a step further in allowing medical facilities to connect with you via API from their EMR systems so that they can share data back and forth between you and them.

Currently, 12 hospitals have signed on to test this beta software including well-known hospitals like: Johns Hopkins Medicine, Penn Medicine, and Cedars-Sinai in Los Angeles. In fact, just last week, Apple had announced this update regarding the Health App bringing together all hospitals and clinics so that it could eventually be easy for all users to have access to their medical data and have a choice when it comes to choosing their provider.

John Halamka, CIO of CareGroup Healthcare Systems saw this innovation and stated that, “Apple is significantly accelerating the provider-to-patient-to-provider approach with IOS 11. 3.” With technology constantly innovating in this space, it’s exciting to see the immense possibilities that will come into play in the years to come.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512